New radiation approach tested for Tough-to-Treat brain tumors
NCT ID NCT01743950
Summary
This study tested a combination treatment for people whose high-grade glioma (a type of brain tumor) had come back after initial therapy. It used a specialized form of radiation given alongside the drug bevacizumab, followed by continued bevacizumab treatment. The main goal was to see if this approach could help patients live longer and control the tumor's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Wisconsin Hospital and Clinics
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.